Department of Emergency Medicine, Research Institute of Clinical Medicine of Chonbuk National University and Biomedical Research Institute of Chonbuk National University Hospital, Jeonju-si, Republic of Korea.
Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
PLoS One. 2018 Apr 5;13(4):e0195628. doi: 10.1371/journal.pone.0195628. eCollection 2018.
This study was aimed at a serial evaluation and comparison of the prognostic values of Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHE) II scores for neurologic outcomes in comatose, out-of-hospital cardiac arrest (OHCA) survivors, treated with targeted temperature management (TTM).
We analysed a prospective cohort of comatose OHCA patients, with TTM, admitted to an emergency intensive care unit (ICU), between January 2010 and December 2015. SOFA and APACHE II scores were calculated initially, and then at day 1, 2, 3, 5, and 7 after ICU admission. Primary and secondary outcomes were the 28-day neurologic outcome and the 28-day mortality, respectively. Prognostic value of the SOFA and APACHE II scores was analysed using the receiver operating characteristic curve.
Of the 143 selected patients, 62 survived and 34 had good neurologic outcomes at day 28. There was no significant difference in the SOFA and extracerebral SOFA scores between the good and poor neurologic outcome groups. However, the APACHE II scores were significantly higher in the good outcome group; they displayed good discriminatory power in predicting poor outcomes, unlike the SOFA scores. The APACHE II score at day 3 had the highest prognostic value for predicting poor neurologic outcomes with an area under the cure of 0.793, and with a cut-off value of 20, the APACHE II score predicted poor neurologic outcomes with a sensitivity of 43.75%, a specificity of 94.12%, a positive predictive value of 94.59%, and a negative predictive value of 41.56%.
Identifying APACHE II score might assist as one piece of multimodal prognostic approach for the assessment of neurologic outcomes in OHCA survivors treated with TTM.
本研究旨在对序贯性器官衰竭评估(SOFA)和急性生理学与慢性健康评估(APACHE)Ⅱ评分在接受目标温度管理(TTM)治疗的昏迷、院外心脏骤停(OHCA)幸存者的神经预后方面进行连续评估和比较。
我们分析了 2010 年 1 月至 2015 年 12 月期间,入住急诊重症监护病房(ICU)、接受 TTM 的昏迷 OHCA 患者的前瞻性队列。最初计算 SOFA 和 APACHE Ⅱ评分,然后在 ICU 入院后第 1、2、3、5 和 7 天进行计算。主要和次要结局分别为 28 天神经预后和 28 天死亡率。使用接收者操作特征曲线分析 SOFA 和 APACHE Ⅱ评分的预后价值。
在 143 名入选患者中,有 62 名患者存活,34 名患者在 28 天时具有良好的神经预后。在神经预后良好和不良的两组之间,SOFA 和非脑 SOFA 评分没有显著差异。然而,APACHE Ⅱ评分在预后良好的组中明显更高;与 SOFA 评分不同,它们在预测不良结局方面具有良好的区分能力。APACHE Ⅱ评分在第 3 天对预测不良神经结局的预测价值最高,曲线下面积为 0.793,截断值为 20 时,APACHE Ⅱ评分预测不良神经结局的敏感性为 43.75%,特异性为 94.12%,阳性预测值为 94.59%,阴性预测值为 41.56%。
识别 APACHE Ⅱ评分可能有助于作为评估接受 TTM 治疗的 OHCA 幸存者神经结局的多模态预后方法之一。